Drug Safety Databases
American Porphyria Foundation
APF Drug Safety Database
This database contains expert assessments of the potential of drugs to provoke attacks of acute porphyria and is intended for use by health care professionals. Compiled by Bo Zhou and Peter V. Tishler, M. D., Channing Laboratory and Genetics Division, Brigham & Women's Hospital, Boston, MA.
Revision 1 — Spring, 2011
EPNET
Nordic Drug Database
The information provided on this website partly arises from the drug data collection within the EPNET project which has received funding from the European Union, in the framework of the Public Health Programme. European Porphyria Network (EPNET). The European Porphyria Network (EPNET) is a health information priority for developing strategies and mechanisms for preventing, exchanging information on and responding to non-communicable disease threats, including rare diseases. EPNET is a project arising from the European Porphyria Intiative (EPI) (www.porphyria-europe.org) funded by the INSERM.
Porphyria South Africa, Universities of Cape Town and KwaZulu-Natal
Cape Town Drug List
Our list contains most drugs available in South Africa at present. Note that new drugs are constantly being introduced, and the absence of a drug from this list does not mean that its safety can be assumed.
The list is presented in two ways: in alphabetical order, and then grouped together into common indications for medication, such as Asthma, Diabetes etc. You can also print out the entire list for your reference. Check back from time to time as we do update it as new information becomes available.
European Porphyria Network
European Drug List
This website contains :
A list of drugs that are considered SAFE
A list of drugs which are considered UNSAFE
Guidance on common prescribing problems
A link to a searchable drug list
APF Drug Safety Database
This database contains expert assessments of the potential of drugs to provoke attacks of acute porphyria and is intended for use by health care professionals. Compiled by Bo Zhou and Peter V. Tishler, M. D., Channing Laboratory and Genetics Division, Brigham & Women's Hospital, Boston, MA.
Revision 1 — Spring, 2011
EPNET
Nordic Drug Database
The information provided on this website partly arises from the drug data collection within the EPNET project which has received funding from the European Union, in the framework of the Public Health Programme. European Porphyria Network (EPNET). The European Porphyria Network (EPNET) is a health information priority for developing strategies and mechanisms for preventing, exchanging information on and responding to non-communicable disease threats, including rare diseases. EPNET is a project arising from the European Porphyria Intiative (EPI) (www.porphyria-europe.org) funded by the INSERM.
Porphyria South Africa, Universities of Cape Town and KwaZulu-Natal
Cape Town Drug List
Our list contains most drugs available in South Africa at present. Note that new drugs are constantly being introduced, and the absence of a drug from this list does not mean that its safety can be assumed.
The list is presented in two ways: in alphabetical order, and then grouped together into common indications for medication, such as Asthma, Diabetes etc. You can also print out the entire list for your reference. Check back from time to time as we do update it as new information becomes available.
European Porphyria Network
European Drug List
This website contains :
A list of drugs that are considered SAFE
A list of drugs which are considered UNSAFE
Guidance on common prescribing problems
A link to a searchable drug list
- Disclaimer : Care has been taken to ensure that the information on this website is accurate at the time of publication. This information is, however, intended for general guidance only. The Alberta Porphyria Society disclaims for itself and for the author of this information, all responsibility for any mis-statements or for consequences of actions taken by any person while acting on information contained herein. Physicians and patients must make their own decisions according to the individual circumstances of each case.
